Scott S. Brooks – Chief Executive Officer
Mr. Brooks is President, Chief Executive Officer, and on the Board of Directors. Scott joined Regenesis Biomedical in January 2012 as the Chief Operating Officer. He has held senior executive positions in four major healthcare organizations. Scott has extensive experience in sales, marketing, and operations. Prior to Regenesis he held the position of President in the U.S. and Canada for BSN Medical located in Charlotte, NC. At BSN Scott was instrumental in developing sales, expanding clinical education programs, and enhancing management development. Prior to BSN, Scott was the VP of Sales and National Accounts for Kinetic Concepts Inc. (KCI), the global leader of advanced wound care devices. During his tenure at KCI, he held senior leadership positions in five different divisions of the company. KCI’s broad device portfolio includes therapy devices designed for advanced wound care, critical care and bariatric care, sold throughout the continuum of care. Scott served on the senior management team as the company emerged into the innovative global leader in advance wound care. He was also instrumental in two mergers and acquisitions, plus negotiated and implemented numerous strategic contracts and alliances. Scott’s experience also includes successful leadership positions with The Hill-Rom Company and Kimberly-Clark Healthcare. Mr. Brooks earned a Bachelor of Arts in Business Administration from Western Washington University.
Dennis Genge – Vice-President and Chief Financial Officer
Mr. Genge joined Regenesis Biomedical in early 2007. During his 35 year career, he has held senior financial executive positions in 4 public and 2 private companies, with a particular emphasis in startup companies who experienced rapid growth, initial product approvals and commercial launches in the medical device, life sciences and health care service industries. In particular, Mr. Genge has directed a Sarbanes Oxley compliance program, taken 2 companies through their initial IPO’s, completed numerous public and private equity and debt offerings, negotiated and implemented multiple strategic alliances with major pharmaceutical companies, managed the merger and acquisition of 6 companies, been responsible for directing the reporting for SEC compliance reporting, managed HR, IT, purchasing, insurance, and facilities operations and directed the implementation of major financial systems. Prior to Regenesis Mr. Genge was a Partner with Tatum, LLC, a Financial Services Practice. Prior to that, he served as Vice-President, CFO and Treasurer of Novavax Inc, a public life sciences company. Before Novavax Dennis was Vice-President and Controller at Pyxis Corporation (a subsidiary of Cardinal Health), a medical supply stations company. He also served as Executive Director of Finance and Corporate Controller at Ligand Pharmaceuticals, a biotechnology company, Vice-President and CFO of Ivonyx HomeCare Services, an IV home therapy company and Executive Director/Controller with IMED Corp. an IV pump company. Mr. Genge began his career as an auditor with Ernst and Young in San Diego. Mr. Genge obtained his CPA license in the state of California and holds a Masters of Business Administration and a Bachelor of Administration with an emphasis in Accounting from Western Michigan University.
Adrianne (Patti) Smith, MD – Vice-President, Medical Affairs & Clinical Business Development
Dr. Smith has a passion for developing best clinical practices to improve patient access to advanced therapies. She gained industry experience in her positions as Vice President and Medical Director at Kinetic Concepts Inc. (KCI), providing medical support for clinicians using the wound V.A.C.®, and Senior Medical Advisor at Diversified Clinical Services (DCS), now merged into Healogics, supporting the clinical outreach of the largest US wound care and hyperbaric oxygen management company. Dr. Smith’s academic appointments have included: the University of Texas Health Science Center Emergency Department, where she served as the Quality Risk Management Director; the Chief of Emergency Services for Scott Air Force Base; and the Medical Director of the Texas Diabetes Institute Hyperbaric Medicine and Wound Care Center. She is a graduate of Duke University and Washington University Medical School, and has authored numerous publications.
Tom Eisiminger, Jr. – Vice-President, Sales
Mr. Eisiminger is a retired United States Army Officer and decorated combat veteran. He joined Regenesis in 2006 after a short tenure with GlaxoSmithKline, initially serving as Clinical Support and Territory Manager, then Northwest Regional Sales Director and Vice President of Sales. Tom held numerous leadership positions in the Army from platoon to battalion command. He managed the largest geographically dispersed Army Recruiting Battalion responsible for operations in SW Washington, Oregon, Northern California, Hawaii, Korea, Japan, Guam, American Samoa, Commonwealth of the Northern Marianas Islands, and the Freely Associated States of the Republic of the Marshall Island, Republic of Palau and the Federated States of Micronesia. He twice earned awards as top recruiting unit in the Army. He earned his B.S. from the U. S. Military Academy at West Point, his M.A. in National Security and Strategic Studies from the Naval War College, and his M.B.A. from Marylhurst University in Portland, Oregon. Tom is a member of the Veterans of Foreign Wars, the American Legion, and the Disabled American Veterans. He is a veteran’s advocate and serves on the Board of Advisors and acts as Chairman of the Southwest Region AdvaMed Veterans Program (MVP) where he mentors transitioning veterans interested in joining the medical technology industry. He also serves as President and on the Board of Directors of the Wounded Warrior Amputee Softball Team, and the Board of Directors of the Warrior Institute of NeuroWellness (WIN)/Horse Rhythm Foundation, a nonprofit organization designed to offer specialized services for veterans, first responders and their families suffering with mental health disorders (PTSD) and physical disabilities (traumatic brain injuries, amputations, etc.) due to combat or public safety tragedies.
Scott Robey – Vice-President, Marketing
Mr. Robey is a 20+ year marketing veteran. Prior to Regenesis he served as Senior Director of Marketing at Kinetic Concepts, Inc (KCI) for the V.A.C. Therapy brand during the time US product sales grew from about $70M in 2000 to about $1 billion by 2007. He has held marketing positions at Medtronic, Sulzer Carbomedics, and Burron Medical (B. Braun Medical, Inc). His responsibilities have included product management, new product development and commercialization, branding, clinical education programs, and key opinion leader and society relationship development. Mr. Robey has an M.S. in Management from Purdue University, and a B.S. in Biomedical Engineering from Louisiana Tech University.
John Moffett – Executive Director, Life Science
John Moffett, Ph.D., joined Regenesis Biomedical in 2003. Dr. Moffett’s research experience includes study at Dana Farber Cancer Institute and The Salk Institute for Biological Studies. His main research focus has been in understanding how biological events and processes are regulated, especially at the molecular and cellular levels. Dr. Moffett’s background is multifaceted and includes hands-on experimental work on a range of biomedical topics, including nutrient metabolism, somatic cell genetics, gene regulation, and protein modulation. His recent studies with Regenesis Biomedical have focused on the understanding of the effects of electromagnetic fields on biological systems. Dr. Moffett attained his B.A. and Ph.D. from the University of California at Santa Barbara.